Abbott reinforces global vascular leadership with new data on innovative ... pharmabiz.com In addition, there will be a number of presentations on Abbott's XIENCE V Everolimus Eluting Coronary Stent System as well as preliminary results from a unique pilot program that screens women for cardiovascular risk factors at obstetrics/gynecology ... Abbott to present MitraClip and Absorb products at ACC 2012 |
